Dilon Technologies

Dilon Technologies

Dilon Technologies Inc. is a medical device manufacturer headquartered in Newport News, Virginia, with an additional office in Caesarea, Israel. The company describes itself as a women's healthcare company that has expanded into biosurgery, developing and promoting innovative medical devices to healthcare providers globally (per the firm's website). Dilon's product lineup includes the Navigator System, a surgical gamma probe for radio-guided lymphatic mapping and tumor localization; MarginProbe, a technology for real-time margin assessment during breast cancer surgery; and the CoPilot VL+, a portable video laryngoscope for airway management. The company also markets HEMOBLAST Bellows, a powdered surgical hemostat combining thrombin, collagen, and chondroitin sulfate. On its website, Dilon reports a presence in over 76 countries and claims its devices have impacted "hundreds of thousands" of lives. The firm does not disclose revenue, AUM, or deployment figures. The company operates from a single disclosed headquarters and an Israeli subsidiary, Dilon Medical Technologies Ltd., located in Caesarea Industrial Park. No information is publicly available regarding the number of employees, founding year, ownership structure, or named principals. The firm's website does not include a team page, investor relations section, or historical milestones. Dilon's structural differentiator is its focus on niche surgical technologies for breast cancer and biosurgery, combining a gamma probe line with margin assessment and hemostatic products. However, the firm's ownership, capital structure, and investment posture remain opaque, with no publicly available details on whether it operates as a family office, private company, or subsidiary of a larger entity.